Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indications. The company is rapidly advancing toward the clinic personalized next-generation immunotherapies for oncology, infectious diseases and autoimmune disease.
Market
Immunotherapy
Location
Philadelphia,
Pennsylvania,
USA
Coinvestors
Be The Match BioTherapies, BrightEdge Ventures, Gilead Sciences, University of Pennsylvania, Westlake Village BioPartners